Results for tag: "Natrecor"

Natrecor (nesiritide) is a cardiovascular drug used to treat acutely decompensated heart failure. It is a recombinant form of human B-type natriuretic peptide (BNP) and is administered intravenously. Natrecor works by increasing the excretion of sodium and water from the body, which helps reduce the amount of fluid in the lungs and other organs. It also helps to reduce the workload on the heart, allowing it to pump more efficiently. Natrecor is used in combination with other medications to treat acute heart failure. Natrecor is a relatively new drug, having been approved by the US Food and Drug Administration in 2001. It is used in hospitals and other healthcare settings to treat acute heart failure. Natrecor is not recommended for long-term use, as it has not been studied in this setting. The Natrecor market is highly competitive, with several companies offering similar products. Some of the major players in the market include AstraZeneca, Merck, Pfizer, and Novartis. Other companies such as Amgen, GlaxoSmithKline, and Sanofi also offer Natrecor-based products. Show Less Read more